While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?
A newly published study suggests that women may respond differently than men to some HIV curative interventions that are currently under investigation or, perhaps, that an effective HIV cure for women could differ from a cure for men.
The National Institutes of Health has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants.
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun and will examine whether cabotegravir injected once every eight weeks can safely protect women at risk for HIV infection...
Clinical trials (the study of new treatments in people) are critical if we are ever to find better ways to treat HIV, and, eventually, a cure. Unfortunately, people of color, women, and IV drug users have been under-represented in these trials for ma...